Cencora, Inc. (0HF3.L)

235.97 -1.62 (-0.68%) At close: 06:30PM BST

Cencora, Inc.

1 West First Avenue
Conshohocken, PA 19428-1800
United States
610 727 7000
https://www.cencora.com

Sector(s): 
Industry: 
Full-time employees: 42,000

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Steven H. Collis	Chairman, President & CEO	5.01M	13.79M	1961
Mr. James F. Cleary Jr.	Executive VP & CFO	1.95M	3.8M	1963
Dr. Robert P. Mauch Ph.D., PharmD	Executive VP & COO	2.7M	N/A	1967
Ms. Gina K. Clark	Executive VP and Chief Communications & Administration Officer	1.57M	5.01M	1957
Ms. Elizabeth S. Campbell	Executive VP & Chief Legal Officer	1.63M	318.67k	1975
Mr. Lazarus Krikorian	Senior VP, Chief Accounting Officer & Corporate Controller	N/A	N/A	1965
Bennett S. Murphy	Senior Vice President of Investor Relations	N/A	N/A	N/A
Ms. Jennifer E. Dubas	Senior VP & Chief Compliance Officer	N/A	N/A	N/A
Ms. Silvana Battaglia	Executive VP & Chief Human Resources Officer	1.58M	N/A	1968
Ms. Leslie E. Donato	Executive VP & Chief Strategy Officer	N/A	N/A	1970

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Corporate governance

Cencora, Inc.’s ISS governance QualityScore as of 1 April 2024 is 3. The pillar scores are Audit: 2; Board: 5; Shareholder rights: 7; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.